fashion -WSS

fashion

author：focus 2025-09-02 08:11:57 - browse：925

Blue numbers and letter falling down a tunnel. -- health tech coverage from STAT — Adobe

A growing number of AI tools are being used to predict everything from sepsis to strokes, with the hope of accelerating the delivery of life-saving care. But over time, new research suggests, these predictive models can become a victim of their own success — sending their performance into a nosedive and generating inaccurate, potentially harmful results.

“There is no accounting for this when your models are being tested,” said Akhil Vaid, an instructor of data-driven and digital medicine at the Icahn School of Medicine at Mount Sinai and author of the new research, published Monday in the Annals of Internal Medicine. “You can’t run validation studies, do external validation, run clinical trials — because all they’ll tell you is that the model works. And when it starts to work, that is when the problems will arise.”

Vaid and his Mount Sinai colleagues simulated the deployment of two models that predicted a patient’s risk of dying and acute kidney injury within five days of entering the ICU. Their simulations assumed that the models did what they were supposed to — lower deaths and kidney injury by identifying patients for earlier intervention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Venture capital firm's plans to take over Akron hospital face hurdles

WSS

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Reconstructing family trees of blood cells may help predict disease

FTC sues over Novant Health acquisition of two N.C. hospitals

At ASCO, AstraZeneca reports strong data for breast cancer drug

Philips to halt sales of sleep apnea machines in U.S.

focus

fashion

hotspot

Bright Health sells Medicare Advantage business to Molina

Shifting the focus from loneliness to social health

Peter Hotez and the public health issue of online harassment

ASCO: Palliative care found as helpful given virtually as in person

Bright Health sells Medicare Advantage business to Molina

Boston competes with Raleigh

Wildfire smoke exposes gaps in outdoor worker protections

Why Medicare shouldn’t cover every FDA

Medicare proposal to cover medical devices draws a mixed reaction

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Wikipedia

Bernie Sanders is gearing up to subpoena pharma CEOs

Ionis drug prevents swelling attacks due to hereditary angioedema

Merck, Johnson & Johnson CEOs will testify on high drug prices

Health Care Service Corp to buy Cigna Medicare Advantage plans

White House pharmacy plagued with problems, investigation finds

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

hotspot

focus

hotspot

hotspot